March 10, 2020 / 12:42 PM / 25 days ago

BRIEF-Daré Bioscience Receives FDA Fast Track Designation For Dare-Bv1 To Treat Bacterial Vaginosis

March 10 (Reuters) - Dare Bioscience Inc:

* DARÉ BIOSCIENCE RECEIVES FDA FAST TRACK DESIGNATION FOR DARE-BV1 FOR THE TREATMENT OF BACTERIAL VAGINOSIS

* DARE BIOSCIENCE - PLANS TO INITIATE PHASE 3 CLINICAL STUDY OF DARE-BV1 IN ABOUT 220 WOMEN WITH ANTICIPATED TOPLINE DATA READOUT BY END OF 2020

* DARE BIOSCIENCE - INTENDS TO FILE NDA FOLLOWING COMPLETION OF PHASE 3 STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below